Do you wonder how to increase online presence of your offline pharmacy? Online pharmacy is the perfect answer to this question.Let’s check how:1. It helps to streamline business2. It improves customer happiness3. It helps to maintain a record of customer orders safely4. It provides insights into customer buying trends5. It improves…
Continue Reading
For the 102nd episode of the Healthcare IT Podcast, we are diving into digital transformation. We begin by examining what digital transformation means to us and what we think it means to others. Next we look at the areas that needs to be transformed the most and what areas need it the least. Then we dive into the barriers that are present in the field of digital transformation and the effect they’ve had on the field. Lastly, we discuss who we think will provide the most transformation.
Here’s a preview of the questions and topics we discuss in this episode:
What does Digital…
Continue Reading
Dr. Bertalan Meskó, PhD is the Medical Futurist. I follow his newsfeeds to get great insights about the future of Healthcare. Website → RSS Feed → LinkedIn → Twitter → Facebook → Instagram → Youtube →
Continue Reading
Healthcare IT Today is one of my favorites. It is a trustworthy source of all things Healthcare IT. You can follow HIT’s newsfeed on MediFormatica’s daily news aggregator. Website → RSS Feeds → Youtube → Podcast → Spotify → Email → Subscription Options →
Continue Reading
Content is targeted to and read by experienced decision-makers who need to stay current on health IT news, rumors, and opinions. Website → RSS Feed → Youtube → Announcements → Email →
Continue Reading
The OMOP Common Data Model allows for the systematic analysis of disparate observational databases. The concept behind this approach is to transform data contained within those databases into a common format (data model) as well as a common representation (terminologies, vocabularies, coding schemes), and then perform systematic analyses using a library of standard analytic routines that have been written based on the common format.
Continue Reading
In this episode of Health+Tech, Andrea Lee Linna and Jonathan Ishee are joined by fellow McGuireWoods digital health team member Michael Paluzzi to discuss proposed HIPAA changes that may require covered entities and business associates to overhaul their HIPAA policies and procedures in 2022.After providing a high-level overview of the proposed changes, the podcast turns to a live recording of Andrea and Jonathan’s recent webinar, “Preparing for Major HIPAA Changes in 2022,” offering in-depth details about the proposed changes and how to prepare for them in the new year….
Continue Reading
In this episode of Health+Tech, McGuireWoods healthcare attorneys Janice Suchyta, Kate Hardey, Kae Gruner and Royce DuBiner discuss the latest digital health updates from the Food and Drug Administration and Federal Trade Commission. Join the conversation as we wrap up Cybersecurity Awareness Month and discuss the following topics:• FDA draft guidance on electronic health records and medical claims data• FDA new resource for approved artificial intelligence/machine learning medical devices• FDA Digital Health Center of Excellence• FTC rules for health apps outside of HIPAA…
Continue Reading
In this episode of Health+Tech, McGuireWoods healthcare partner Janice Suchyta talks to Michele Satterlund, senior vice president in the state government relations practice of McGuireWoods Consulting and a partner with McGuireWoods, on the emergence of telehealth, particularly during the pandemic. They also look at how telehealth is evaluated state by state and discuss the need for uniform best practices….
Continue Reading
In this episode of Health+Tech, McGuireWoods healthcare partner Janice M. Suchyta talks to Donna Chang, founder and CEO of Hope Biosciences. Donna discusses how Texas — particularly Houston — is making a name for itself in biotechnology by attracting research funding, supporting premier academic medical centers and welcoming investment by major pharmaceutical companies. Hope Biosciences, a stem cell biotechnology company that has flourished as part of the biotech cluster in the Houston area, is helping to make Texas the third coast for biotechnology….
Continue Reading
